Amgen is investing $200 million in its new technology and innovation center in Hyderabad to enhance AI and data-driven drug development. 

Amgen CEO Robert Bradway, speaking at the site's inauguration, confirmed plans for further investments in the coming years.

The Hyderabad facility, announced last year, aims to accelerate medicine development through cutting-edge technology. By year-end, it is expected to employ 2,000 people, with 300 already on board, according to Som Chattopadhyay, Amgen's national executive for India.

Amgen’s expansion aligns with India’s growing role as the “pharmacy of the world,” attracting global pharmaceutical giants.